Web Analytics

Investor Profile

Goldman Sachs Asset Management

Goldman Sachs Asset Management United Kingdom - London, England
INVESTOR

1 Disclosed Funding Rounds $35,000,000
35 Participating Investments




Bringing together traditional and alternative investments, we provide clients around the world with a dedicated partnership and focus on long-term performance. As the primary investing area w

Invested In

Company Date Round Raised
  Limble CMMS June, 22 ,2023 Series B $58,000,000
  Resilia October, 31 ,2022 Series B $35,000,000
  Septerna July, 18 ,2023 Series B $150,000,000
  Mews December, 16 ,2022 Series C $185,000,000
  Fortanix September, 15 ,2022 Series C $90,000,000
  Bowery Valuation July, 19 ,2023 Series B $16,300,000
  Netskope January, 06 ,2023 Debt Round $401,000,000
  Solink July, 26 ,2023 Series C $60,000,000
  Mayvenn July, 13 ,2022 Series C $40,000,000
  Candex November, 30 ,2023 Series B $45,000,000
  Zilch June, 30 ,2022 Series C $50,000,000
  Bastille January, 26 ,2024 Series C $44,000,000
  AlphaSense June, 15 ,2022 Series D $225,000,000
  Alterome Therapeutics, Inc April, 09 ,2024 Series B $132,000,000
  MoEngage June, 01 ,2022 Series E $77,000,000
  RippleMatch June, 12 ,2022 Series B $45,000,000
  Kontakt.io April, 19 ,2024 Unknown $47,500,000
  Rimac Technology June, 02 ,2022 Series D $536,000,000
  Vicebio September, 24 ,2024 Series B $100,000,000
  WSO2 May, 25 ,2022 Series E $3,000,000
  Desia October, 01 ,2024 Pre-Seed $3,300,000
  Caribou May, 23 ,2022 Series C $115,000,000
  Mahmee May, 12 ,2022 Series A $9,200,000
  Impact Nano May, 08 ,2023 Unknown $32,000,000
  Madhive June, 16 ,2023 Unknown $300,000,000
  Limble CMMS June, 22 ,2023 Series B $58,000,000
  Septerna July, 18 ,2023 Series B $150,000,000
  Bowery Valuation July, 19 ,2023 Series B $16,300,000
  Solink July, 26 ,2023 Series C $60,000,000
  Candex November, 30 ,2023 Series B $45,000,000
  Bastille January, 26 ,2024 Series C $44,000,000
  Alterome Therapeutics, Inc April, 09 ,2024 Series B $132,000,000
  Kontakt.io April, 19 ,2024 Unknown $47,500,000
  Vicebio September, 24 ,2024 Series B $100,000,000
  Desia October, 01 ,2024 Pre-Seed $3,300,000